Martha K Leijsma
Overview
Explore the profile of Martha K Leijsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arends S, Spoorenberg A, Efde M, Bos R, Leijsma M, Bootsma H, et al.
PLoS One
. 2014 Jun;
9(6):e99685.
PMID: 24918782
Introduction: Ankylosing spondylitis (AS) is characterized by excessive bone formation and bone loss. Our aim was to investigate the association of bone turnover markers (BTM) with spinal radiographic damage and...
2.
Knevel R, de Rooy D, Saxne T, Lindqvist E, Leijsma M, Daha N, et al.
Arthritis Res Ther
. 2014 Jun;
16(3):R108.
PMID: 24886600
Introduction: Progression of joint destruction in rheumatoid arthritis (RA) is partly heritably; 45 to 58% of the variance in joint destruction is estimated to be explained by genetic factors. The...
3.
de Rooy D, Yeremenko N, Wilson A, Knevel R, Lindqvist E, Saxne T, et al.
Ann Rheum Dis
. 2012 Oct;
72(5):769-75.
PMID: 23041840
Background: Progression of joint destruction in rheumatoid arthritis (RA) is partly heritable; knowledge of genetic factors may increase our understanding of the mechanisms underlying joint destruction. The activity of the...
4.
Vos L, Huddleston Slater J, Leijsma M, Stegenga B
J Orofac Pain
. 2012 Jul;
26(3):233-9.
PMID: 22838008
Aims: To determine the available evidence in the literature for whether hypoxia-reperfusion injury plays a role in the pathogenesis of joint diseases in general and of osteoarthritis (OA) of the...
5.
Arends S, Spoorenberg A, Houtman P, Leijsma M, Bos R, Kallenberg C, et al.
Arthritis Res Ther
. 2012 May;
14(2):R98.
PMID: 22546520
Introduction: The aim of this study was to investigate the effect of three years of tumor necrosis factor-alpha (TNF-α) blocking therapy on bone turnover as well as to analyze the...
6.
de Vries W, Koppelman G, Roofthooft M, Bootsma H, Leijsma M, Armbrust W
Pediatr Rheumatol Online J
. 2011 Aug;
9:19.
PMID: 21816089
We present the case of an 11-year-old boy presenting with haemoptysis, dyspnoea and weight loss as a manifestation of isolated pulmonary vasculitis, leading to pulmonary hypertension. He also appeared to...
7.
Arends S, Brouwer E, van der Veer E, Groen H, Leijsma M, Houtman P, et al.
Arthritis Res Ther
. 2011 Jun;
13(3):R94.
PMID: 21689401
Introduction: Identifying ankylosing spondylitis (AS) patients who are likely to benefit from tumor necrosis factor-alpha (TNF-α) blocking therapy is important, especially in view of the costs and potential side effects...
8.
Arends S, van der Veer E, Groen H, Houtman P, Jansen T, Leijsma M, et al.
J Rheumatol
. 2011 Jun;
38(8):1644-50.
PMID: 21632677
Objective: To investigate whether level of serum matrix metalloproteinase-3 (MMP-3) can serve as a biomarker for monitoring and predicting response to etanercept treatment in patients with ankylosing spondylitis (AS) in...
9.
Hazenberg A, Dikkers F, Hawkins P, Bijzet J, Rowczenio D, Gilbertson J, et al.
Laryngoscope
. 2009 Feb;
119(3):608-15.
PMID: 19235761
Objective: To study the clinical and pathological characteristics of two patients with laryngeal apolipoprotein A-I (apoA-I)-derived (AApoAI) amyloidosis with the apolipoprotein A-I variants Leu174Ser and Leu178Pro, respectively. The latter variant...
10.
Meijer J, Schonland S, Palladini G, Merlini G, Hegenbart U, Ciocca O, et al.
Arthritis Rheum
. 2008 Jun;
58(7):1992-9.
PMID: 18576343
Objective: To report 8 patients with Sjögren's syndrome (SS) and localized nodular cutaneous amyloidosis and to examine serologic and immunohistologic findings that may link the 2 diseases. Methods: The databases...